HHS IG Notice On Clinical Trials Coverage Overlooks Private Studies
This article was originally published in The Gray Sheet
Executive Summary
Possible exceptions to federal civil money penalties associated with Medicare fraud and abuse over clinical trial participation "inducements" are being sought by the HHS Office of the Inspector General
You may also be interested in...
Clinical Trial New Device Coverage Key For Small Firms, AbioMed Exec Says
A provision authorizing Medicare to cover routine costs of clinical trials for investigational devices likely will be attached to prescription drug legislation due after lawmakers return from the Memorial Day recess June 2
Clinical Trial New Device Coverage Key For Small Firms, AbioMed Exec Says
A provision authorizing Medicare to cover routine costs of clinical trials for investigational devices likely will be attached to prescription drug legislation due after lawmakers return from the Memorial Day recess June 2
J&J’s Longstreet: Medicare, Global Payment Reforms Move To Front Of Queue
Medicare reforms for small manufacturers, MDUFMA implementation and the need to step up international lobbying efforts are 2003 priorities to be stressed by AdvaMed Chairman Dennis Longstreet at the trade group's annual meeting in Aventura, Fla. March 19-22